-
Symbol
-
RNAZ on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
83.3K shares
-
Security Ownership
-
9.1%
CK Life Sciences Int'l., (Holdings) Inc. ownership in Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share (RNAZ)
28 Oct 2025 - CK Life Sciences Int'l., (Holdings) Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 83.3K shares of Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share (RNAZ).
This represents 9.1% percent ownership of the company.